130 related articles for article (PubMed ID: 14973390)
21. Expression of steroid hormone receptors, their regulated proteins, and bcl-2 protein in myofibroblastoma of the breast.
Magro G; Bisceglia M; Michal M
Histopathology; 2000 Jun; 36(6):515-21. PubMed ID: 10849093
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
[TBL] [Abstract][Full Text] [Related]
23. [Neuroendocrine carcinoma of breast: a study of tumor morphology and subtyping].
Gao LX; Liu G; Li L; Lin HY; Jin H; Cheng J; Jin ML; Ding HY
Zhonghua Bing Li Xue Za Zhi; 2011 Sep; 40(9):604-9. PubMed ID: 22177244
[TBL] [Abstract][Full Text] [Related]
24. Male breast cancer: immunohistochemical subtypes and clinical outcome characterization.
Sánchez-Muñoz A; Román-Jobacho A; Pérez-Villa L; Sánchez-Rovira P; Miramón J; Pérez D; Sáez MI; de Luque V; Medina L; Ramírez-Tortosa CL; Vicioso L; Medina JA; Ribelles N; Alba E
Oncology; 2012; 83(4):228-33. PubMed ID: 22907070
[TBL] [Abstract][Full Text] [Related]
25. Bcl-2 expression in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Virchows Arch; 1998 Sep; 433(3):229-35. PubMed ID: 9769126
[TBL] [Abstract][Full Text] [Related]
26. Proliferative activity and steroid hormone receptor status in male breast carcinoma.
Muñoz de Toro MM; Maffini MV; Kass L; Luque EH
J Steroid Biochem Mol Biol; 1998 Nov; 67(4):333-9. PubMed ID: 9883990
[TBL] [Abstract][Full Text] [Related]
27. Hormone Receptor-Positive Breast Cancer Has a Worse Prognosis in Male Than in Female Patients.
Li X; Yang J; Krishnamurti U; Huo L; Ward KC; O'Regan R; Peng L
Clin Breast Cancer; 2017 Aug; 17(5):356-366. PubMed ID: 28576631
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic characteristics of male breast cancer: a report of 21 cases in radiotherapy center of hamedan, iran.
Sedighi A; Hamed EA; Mohammadian K; Behnood S; Kalaghchi B
Asian Pac J Cancer Prev; 2013; 14(12):7381-3. PubMed ID: 24460307
[TBL] [Abstract][Full Text] [Related]
29. Prognostic implications of the intrinsic molecular subtypes in male breast cancer.
Abdeljaoued S; Lhem B; Nasri M; Adouni O; Goucha GA; Bouzaiene H; Boussen H; Rahal RK; Gamoudi GA
J BUON; 2017; 22(2):377-382. PubMed ID: 28534358
[TBL] [Abstract][Full Text] [Related]
30. Familial and sporadic breast cancers: differences in clinical, histopathological, and immunohistochemical features.
D'Eredita' G; Giardina C; Napoli A; Troilo VL; Fischetti F; Berardi T
Int J Surg Pathol; 2011 Dec; 19(6):724-32. PubMed ID: 20308044
[TBL] [Abstract][Full Text] [Related]
31. Male breast carcinoma: correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases.
Wang-Rodriguez J; Cross K; Gallagher S; Djahanban M; Armstrong JM; Wiedner N; Shapiro DH
Mod Pathol; 2002 Aug; 15(8):853-61. PubMed ID: 12181271
[TBL] [Abstract][Full Text] [Related]
32. Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study.
Wilder JL; Shajahan S; Khattar NH; Wilder DM; Yin J; Rushing RS; Beaven R; Kaetzel C; Ueland FR; van Nagell JR; Kryscio RJ; Lele SM
Gynecol Oncol; 2004 Feb; 92(2):553-8. PubMed ID: 14766247
[TBL] [Abstract][Full Text] [Related]
33. Steroid hormone receptor expression in male breast cancer.
Murphy CE; Carder PJ; Lansdown MR; Speirs V
Eur J Surg Oncol; 2006 Feb; 32(1):44-7. PubMed ID: 16260112
[TBL] [Abstract][Full Text] [Related]
34. Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome.
Joshi MG; Lee AK; Loda M; Camus MG; Pedersen C; Heatley GJ; Hughes KS
Cancer; 1996 Feb; 77(3):490-8. PubMed ID: 8630956
[TBL] [Abstract][Full Text] [Related]
35. Male breast cancer: a multicentric study.
Culell P; Solernou L; Tarazona J; Roma J; Martí E; Miguel A; Buxó J; Yanguas C; Badal JM
Breast J; 2007; 13(2):213-5. PubMed ID: 17319872
[No Abstract] [Full Text] [Related]
36. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
37. Correlation of immunocytochemical and immunohistochemical determination of estrogen and progesterone receptors in breast cancer.
Zoppi JA; Rotundo AV; Sundblad AS
Acta Cytol; 2002; 46(2):337-40. PubMed ID: 11917582
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of apocrine breast lesions. Consistent over-expression of androgen receptor accompanied by the loss of estrogen and progesterone receptors in apocrine metaplasia and apocrine carcinoma in situ.
Gatalica Z
Pathol Res Pract; 1997; 193(11-12):753-8. PubMed ID: 9521507
[TBL] [Abstract][Full Text] [Related]
39. Male breast cancers behave differently in elderly patients.
Tural D; Selçukbiricik F; Aydoğan F; Beşe N; Yetmen O; Ilvan Ş; Büyükünal E; Serdengeçti S
Jpn J Clin Oncol; 2013 Jan; 43(1):22-7. PubMed ID: 23159765
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor beta is coexpressed with ERalpha and PR and associated with nodal status, grade, and proliferation rate in breast cancer.
Järvinen TA; Pelto-Huikko M; Holli K; Isola J
Am J Pathol; 2000 Jan; 156(1):29-35. PubMed ID: 10623650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
